Stay updated on Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a new build/version of the page.
    Difference
    0.1%
    Check dated 2026-08-29T23:58:13.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    A new page revision label v3.6.5 was added, replacing the previous revision v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-08T23:26:57.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, indicating a new version of the entry.
    Difference
    0.1%
    Check dated 2026-07-25T16:32:43.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The Study Details page shows a new revision tag (v3.6.3) replacing the previous v3.6.2, indicating a minor maintenance update to the page.
    Difference
    0.1%
    Check dated 2026-07-04T04:25:41.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a new release of the page without altering study information.
    Difference
    0.1%
    Check dated 2026-06-27T02:49:55.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Added recruitment status and new user guidance sections to the study details page to clarify enrollment and participation steps. Included minor formatting changes to a heading and updated the revision label from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:39:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Doxorubicin in Endometrial Cancer Clinical Trial page.